Adapalene gel 0.1% in the treatment of infantile acne: an open clinical study.

Abstract

Infantile acne is an uncommon condition in pediatric age. We determined the efficacy and safety of adapalene gel 0.1% in the treatment of infantile acne. Twelve patients were enrolled for adapalene gel 0.1% application once daily over a 16-week treatment period. Efficacy evaluation included counting the inflammatory and noninflammatory lesions by the physician and global evaluation of the improvement. After 16 weeks all patients were followed up for a 1-year period. The time of clearance of the infantile acne lesions was 3 months in four (33%) patients and 4 months in eight (67%) patients (median 3.4 months). Adapalene gel produced reductions in noninflammatory and inflammatory lesions counts. Limited side effects were observed and none of them required stopping the therapy. No patient was left with scarring. Three patients were showed mild lesions in the 1-year follow-up period. Adapalene gel 0.1% was found to be a highly effective and safe drug in the treatment of mild-to-moderate infantile acne.

• Authors: Osman Kose, Erol Koç, Ercan Arca
• Journal: Pediatric dermatology (Pediatr Dermatol) 2008 May-Jun Vol. 25 Issue 3 Pg. 383-6 ISSN: 1525-1470 [Electronic] United States
• PMID: 18577052 (Publication Type: Clinical Trial, Journal Article)

Chemical References

• Dermatologic Agents
• Gels
• Naphthalenes
• Adapalene

Topics

• Acne Vulgaris (drug therapy, pathology)
• Adapalene
• Administration, Cutaneous
• Analysis of Variance
• Child, Preschool
• Dermatologic Agents (adverse effects, therapeutic use)
• Erythema (chemically induced)
• Face (pathology)
• Female
• Gels
• Humans
• Infant
• Male
• Naphthalenes (adverse effects, therapeutic use)
• Pain (chemically induced)
• Pruritus (chemically induced)
• Skin (pathology)
• Statistics, Nonparametric
• Treatment Outcome